See what questions
a doctor would ask.
HIV-1K: HIV is an immune system disease caused by the HIV virus. AIDS is a term used when a person infected with HIV has a CD4+ T cell count below 200 or 14% of lymphocytes. AIDS is an advanced form of HIV. To be classified as AIDS the person must also have an AIDS-related condition such as opportunistic infections. Once a person has been diagnosed with AIDS, even if treatment improved their CD4+ T cell count and infections are under control, the person is still considered to have AIDS. HIV is classified into two subtypes - HIV-1 and HIV-2. HIV-1 is further classified into three groups - Group M, N and O. Group M is further classified into 9 subgroups - A to K and CRFs. CRF's are circulating recombinant forms which are a combination of any two subtypes e.g. CRF A/C involves both And C subtypes. HIV-1, Group M, subtype K is most prevalent in the Democratic Republic of Congo and Cameroon. More detailed information about the symptoms, causes, and treatments of HIV-1K is available below.
Home medical testing related to HIV-1K:
Review possible medical complications related to HIV-1K:
Read more about causes of HIV-1K.
Commonly undiagnosed diseases in related medical categories:
Whooping cough often undiagnosed: Although most children in the Western world have been immunized against whooping cough (also called "pertussis"), this protection wears off after about 15 years. Thus, any teen or adult with a persistent...read more »
Research related physicians and medical specialists:
Other doctor, physician and specialist research services:
Research quality ratings and patient safety measures for medical facilities in specialties related to HIV-1K:
Choosing the Best Hospital: More general information, not necessarily in relation to HIV-1K, on hospital performance and surgical care quality:
Prognosis for HIV-1K: Death usually occurs between 6 and 19 months after diagnosis of AIDS if not treatment is utilized. Strict adherence to treatment plans (usually antiretroviral medications) can significantly improve long-term outcomes. A number of people will develop a resistance to treatment therapies if they have been on them for more than two decades.
Read about other experiences, ask a question about HIV-1K, or answer someone else's question, on our message boards:
Search Specialists by State and City